Intellectual Property India Publishes Patent Application for 'Bezuclastinib Formulations' Filed by Cogent Biosciences, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517067425 A) filed by Cogent Biosciences, Inc., Waltham, U.S.A., on July 15, for 'bezuclastinib formulations.'

Inventor(s) include Barnett, Bradley; Rosinovsky, Elodie; Sahin, Hulya; and Crowley, Michael M.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "The disclosure relates to formulations of bezuclastinib, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of c-Kit protein kinases and /or mutant c-kit protein kinases."

The patent application was internationally filed on Dec. 21, 2023, under International application No.PCT/US2023/085459.

Disclaimer: Curated by HT Syndication.